Physician profile
Ali S Williams
NPI 1902182090
$2,412.95
in general payments reported to CMS, 2019-2025
12 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $642 · 2022: $787 · 2023: $578 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.31 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $870.51 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $347.77 | 2022-2025 | Invega Sustenna, Invega Trinza |
| Otsuka America Pharmaceutical, INC. | $314.61 | 2021-2025 | Abilify Maintena, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $252.67 | 2021-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $149.06 | 2023-2025 | Uzedy, Austedo, Austedo Xr |
| Allergan, INC. | $142.99 | 2022 | |
| Alkermes, INC. | $131.90 | 2021-2025 | Aristada, Lybalvi, Aristada Initio |
| Merz North America, INC. | $87.62 | 2025 | |
| Indivior INC. | $46.02 | 2023 | Perseris |
| Lundbeck LLC | $31.31 | 2021-2023 | Rexulti |
| Vanda Pharmaceuticals INC. | $21.54 | 2025 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $16.95 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.